Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Alirocumab Market Growth 2022-2028

  • LP 4974075
  • 127 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Alirocumab will have significant change from previous year. According to our (LP Information) latest study, the global Alirocumab market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Alirocumab market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Alirocumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Alirocumab market, reaching US$ million by the year 2028. As for the Europe Alirocumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Alirocumab players cover AK Scientific, Carbosynth, TargetMol Chemicals, and Beijing Aomi Jiade Pharmaceutical Technology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Alirocumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Patent

Generic

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Biochemical Reagents

Pharmaceutical Intermediates

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AK Scientific

Carbosynth

TargetMol Chemicals

Beijing Aomi Jiade Pharmaceutical Technology

Hefei Hirisun Pharmatech

Hubei Widely Chemical Technology

Hubei Xingcheng Biotechnology

Hubei Zhongshan Medical Technology

Jiangxi Ruiweier Biotechnology

Kailide Biomedical Technology

Nantong Feiyu Biological Technology

Nantong Hi-Future Biotechnology

Shanghai Baishikai Chemical Technology

Shanghai Biochempartner

Shanghai Loulan Biotechnology

Shanghai Macklin Biochemical

Shanghai Minkai Biotechnology

Shanghai Ruihui Chemical Technology

Shanghai Saimai Biotechnology

Shanghai Yifei Biotechnology

Sichuan Weiqi Biotechnology

Taizhou KEDE Chemical

Taizhou Kerui Bio-Technology

Tianmen Hengchang Chemical

WeiShi Reagent

Wuhan Dingxintong Pharmaceutical

Wuhan Fortuna Chemical

Wuhan Sunrise Technology Development

Wuhan Weisman Bioengineering

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alirocumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Alirocumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Alirocumab by Country/Region, 2017, 2022 & 2028

2.2 Alirocumab Segment by Type

2.2.1 Patent

2.2.2 Generic

2.3 Alirocumab Sales by Type

2.3.1 Global Alirocumab Sales Market Share by Type (2017-2022)

2.3.2 Global Alirocumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Alirocumab Sale Price by Type (2017-2022)

2.4 Alirocumab Segment by Application

2.4.1 Biochemical Reagents

2.4.2 Pharmaceutical Intermediates

2.5 Alirocumab Sales by Application

2.5.1 Global Alirocumab Sale Market Share by Application (2017-2022)

2.5.2 Global Alirocumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Alirocumab Sale Price by Application (2017-2022)

3 Global Alirocumab by Company

3.1 Global Alirocumab Breakdown Data by Company

3.1.1 Global Alirocumab Annual Sales by Company (2020-2022)

3.1.2 Global Alirocumab Sales Market Share by Company (2020-2022)

3.2 Global Alirocumab Annual Revenue by Company (2020-2022)

3.2.1 Global Alirocumab Revenue by Company (2020-2022)

3.2.2 Global Alirocumab Revenue Market Share by Company (2020-2022)

3.3 Global Alirocumab Sale Price by Company

3.4 Key Manufacturers Alirocumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Alirocumab Product Location Distribution

3.4.2 Players Alirocumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Alirocumab by Geographic Region

4.1 World Historic Alirocumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Alirocumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Alirocumab Annual Revenue by Geographic Region

4.2 World Historic Alirocumab Market Size by Country/Region (2017-2022)

4.2.1 Global Alirocumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Alirocumab Annual Revenue by Country/Region

4.3 Americas Alirocumab Sales Growth

4.4 APAC Alirocumab Sales Growth

4.5 Europe Alirocumab Sales Growth

4.6 Middle East & Africa Alirocumab Sales Growth

5 Americas

5.1 Americas Alirocumab Sales by Country

5.1.1 Americas Alirocumab Sales by Country (2017-2022)

5.1.2 Americas Alirocumab Revenue by Country (2017-2022)

5.2 Americas Alirocumab Sales by Type

5.3 Americas Alirocumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alirocumab Sales by Region

6.1.1 APAC Alirocumab Sales by Region (2017-2022)

6.1.2 APAC Alirocumab Revenue by Region (2017-2022)

6.2 APAC Alirocumab Sales by Type

6.3 APAC Alirocumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Alirocumab by Country

7.1.1 Europe Alirocumab Sales by Country (2017-2022)

7.1.2 Europe Alirocumab Revenue by Country (2017-2022)

7.2 Europe Alirocumab Sales by Type

7.3 Europe Alirocumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alirocumab by Country

8.1.1 Middle East & Africa Alirocumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Alirocumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Alirocumab Sales by Type

8.3 Middle East & Africa Alirocumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Alirocumab

10.3 Manufacturing Process Analysis of Alirocumab

10.4 Industry Chain Structure of Alirocumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Alirocumab Distributors

11.3 Alirocumab Customer

12 World Forecast Review for Alirocumab by Geographic Region

12.1 Global Alirocumab Market Size Forecast by Region

12.1.1 Global Alirocumab Forecast by Region (2023-2028)

12.1.2 Global Alirocumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Alirocumab Forecast by Type

12.7 Global Alirocumab Forecast by Application

13 Key Players Analysis

13.1 AK Scientific

13.1.1 AK Scientific Company Information

13.1.2 AK Scientific Alirocumab Product Offered

13.1.3 AK Scientific Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AK Scientific Main Business Overview

13.1.5 AK Scientific Latest Developments

13.2 Carbosynth

13.2.1 Carbosynth Company Information

13.2.2 Carbosynth Alirocumab Product Offered

13.2.3 Carbosynth Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Carbosynth Main Business Overview

13.2.5 Carbosynth Latest Developments

13.3 TargetMol Chemicals

13.3.1 TargetMol Chemicals Company Information

13.3.2 TargetMol Chemicals Alirocumab Product Offered

13.3.3 TargetMol Chemicals Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 TargetMol Chemicals Main Business Overview

13.3.5 TargetMol Chemicals Latest Developments

13.4 Beijing Aomi Jiade Pharmaceutical Technology

13.4.1 Beijing Aomi Jiade Pharmaceutical Technology Company Information

13.4.2 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offered

13.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Beijing Aomi Jiade Pharmaceutical Technology Main Business Overview

13.4.5 Beijing Aomi Jiade Pharmaceutical Technology Latest Developments

13.5 Hefei Hirisun Pharmatech

13.5.1 Hefei Hirisun Pharmatech Company Information

13.5.2 Hefei Hirisun Pharmatech Alirocumab Product Offered

13.5.3 Hefei Hirisun Pharmatech Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hefei Hirisun Pharmatech Main Business Overview

13.5.5 Hefei Hirisun Pharmatech Latest Developments

13.6 Hubei Widely Chemical Technology

13.6.1 Hubei Widely Chemical Technology Company Information

13.6.2 Hubei Widely Chemical Technology Alirocumab Product Offered

13.6.3 Hubei Widely Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hubei Widely Chemical Technology Main Business Overview

13.6.5 Hubei Widely Chemical Technology Latest Developments

13.7 Hubei Xingcheng Biotechnology

13.7.1 Hubei Xingcheng Biotechnology Company Information

13.7.2 Hubei Xingcheng Biotechnology Alirocumab Product Offered

13.7.3 Hubei Xingcheng Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hubei Xingcheng Biotechnology Main Business Overview

13.7.5 Hubei Xingcheng Biotechnology Latest Developments

13.8 Hubei Zhongshan Medical Technology

13.8.1 Hubei Zhongshan Medical Technology Company Information

13.8.2 Hubei Zhongshan Medical Technology Alirocumab Product Offered

13.8.3 Hubei Zhongshan Medical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hubei Zhongshan Medical Technology Main Business Overview

13.8.5 Hubei Zhongshan Medical Technology Latest Developments

13.9 Jiangxi Ruiweier Biotechnology

13.9.1 Jiangxi Ruiweier Biotechnology Company Information

13.9.2 Jiangxi Ruiweier Biotechnology Alirocumab Product Offered

13.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jiangxi Ruiweier Biotechnology Main Business Overview

13.9.5 Jiangxi Ruiweier Biotechnology Latest Developments

13.10 Kailide Biomedical Technology

13.10.1 Kailide Biomedical Technology Company Information

13.10.2 Kailide Biomedical Technology Alirocumab Product Offered

13.10.3 Kailide Biomedical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Kailide Biomedical Technology Main Business Overview

13.10.5 Kailide Biomedical Technology Latest Developments

13.11 Nantong Feiyu Biological Technology

13.11.1 Nantong Feiyu Biological Technology Company Information

13.11.2 Nantong Feiyu Biological Technology Alirocumab Product Offered

13.11.3 Nantong Feiyu Biological Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Nantong Feiyu Biological Technology Main Business Overview

13.11.5 Nantong Feiyu Biological Technology Latest Developments

13.12 Nantong Hi-Future Biotechnology

13.12.1 Nantong Hi-Future Biotechnology Company Information

13.12.2 Nantong Hi-Future Biotechnology Alirocumab Product Offered

13.12.3 Nantong Hi-Future Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nantong Hi-Future Biotechnology Main Business Overview

13.12.5 Nantong Hi-Future Biotechnology Latest Developments

13.13 Shanghai Baishikai Chemical Technology

13.13.1 Shanghai Baishikai Chemical Technology Company Information

13.13.2 Shanghai Baishikai Chemical Technology Alirocumab Product Offered

13.13.3 Shanghai Baishikai Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai Baishikai Chemical Technology Main Business Overview

13.13.5 Shanghai Baishikai Chemical Technology Latest Developments

13.14 Shanghai Biochempartner

13.14.1 Shanghai Biochempartner Company Information

13.14.2 Shanghai Biochempartner Alirocumab Product Offered

13.14.3 Shanghai Biochempartner Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shanghai Biochempartner Main Business Overview

13.14.5 Shanghai Biochempartner Latest Developments

13.15 Shanghai Loulan Biotechnology

13.15.1 Shanghai Loulan Biotechnology Company Information

13.15.2 Shanghai Loulan Biotechnology Alirocumab Product Offered

13.15.3 Shanghai Loulan Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shanghai Loulan Biotechnology Main Business Overview

13.15.5 Shanghai Loulan Biotechnology Latest Developments

13.16 Shanghai Macklin Biochemical

13.16.1 Shanghai Macklin Biochemical Company Information

13.16.2 Shanghai Macklin Biochemical Alirocumab Product Offered

13.16.3 Shanghai Macklin Biochemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shanghai Macklin Biochemical Main Business Overview

13.16.5 Shanghai Macklin Biochemical Latest Developments

13.17 Shanghai Minkai Biotechnology

13.17.1 Shanghai Minkai Biotechnology Company Information

13.17.2 Shanghai Minkai Biotechnology Alirocumab Product Offered

13.17.3 Shanghai Minkai Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Shanghai Minkai Biotechnology Main Business Overview

13.17.5 Shanghai Minkai Biotechnology Latest Developments

13.18 Shanghai Ruihui Chemical Technology

13.18.1 Shanghai Ruihui Chemical Technology Company Information

13.18.2 Shanghai Ruihui Chemical Technology Alirocumab Product Offered

13.18.3 Shanghai Ruihui Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Shanghai Ruihui Chemical Technology Main Business Overview

13.18.5 Shanghai Ruihui Chemical Technology Latest Developments

13.19 Shanghai Saimai Biotechnology

13.19.1 Shanghai Saimai Biotechnology Company Information

13.19.2 Shanghai Saimai Biotechnology Alirocumab Product Offered

13.19.3 Shanghai Saimai Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Shanghai Saimai Biotechnology Main Business Overview

13.19.5 Shanghai Saimai Biotechnology Latest Developments

13.20 Shanghai Yifei Biotechnology

13.20.1 Shanghai Yifei Biotechnology Company Information

13.20.2 Shanghai Yifei Biotechnology Alirocumab Product Offered

13.20.3 Shanghai Yifei Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Shanghai Yifei Biotechnology Main Business Overview

13.20.5 Shanghai Yifei Biotechnology Latest Developments

13.21 Sichuan Weiqi Biotechnology

13.21.1 Sichuan Weiqi Biotechnology Company Information

13.21.2 Sichuan Weiqi Biotechnology Alirocumab Product Offered

13.21.3 Sichuan Weiqi Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Sichuan Weiqi Biotechnology Main Business Overview

13.21.5 Sichuan Weiqi Biotechnology Latest Developments

13.22 Taizhou KEDE Chemical

13.22.1 Taizhou KEDE Chemical Company Information

13.22.2 Taizhou KEDE Chemical Alirocumab Product Offered

13.22.3 Taizhou KEDE Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Taizhou KEDE Chemical Main Business Overview

13.22.5 Taizhou KEDE Chemical Latest Developments

13.23 Taizhou Kerui Bio-Technology

13.23.1 Taizhou Kerui Bio-Technology Company Information

13.23.2 Taizhou Kerui Bio-Technology Alirocumab Product Offered

13.23.3 Taizhou Kerui Bio-Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Taizhou Kerui Bio-Technology Main Business Overview

13.23.5 Taizhou Kerui Bio-Technology Latest Developments

13.24 Tianmen Hengchang Chemical

13.24.1 Tianmen Hengchang Chemical Company Information

13.24.2 Tianmen Hengchang Chemical Alirocumab Product Offered

13.24.3 Tianmen Hengchang Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Tianmen Hengchang Chemical Main Business Overview

13.24.5 Tianmen Hengchang Chemical Latest Developments

13.25 WeiShi Reagent

13.25.1 WeiShi Reagent Company Information

13.25.2 WeiShi Reagent Alirocumab Product Offered

13.25.3 WeiShi Reagent Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 WeiShi Reagent Main Business Overview

13.25.5 WeiShi Reagent Latest Developments

13.26 Wuhan Dingxintong Pharmaceutical

13.26.1 Wuhan Dingxintong Pharmaceutical Company Information

13.26.2 Wuhan Dingxintong Pharmaceutical Alirocumab Product Offered

13.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Wuhan Dingxintong Pharmaceutical Main Business Overview

13.26.5 Wuhan Dingxintong Pharmaceutical Latest Developments

13.27 Wuhan Fortuna Chemical

13.27.1 Wuhan Fortuna Chemical Company Information

13.27.2 Wuhan Fortuna Chemical Alirocumab Product Offered

13.27.3 Wuhan Fortuna Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Wuhan Fortuna Chemical Main Business Overview

13.27.5 Wuhan Fortuna Chemical Latest Developments

13.28 Wuhan Sunrise Technology Development

13.28.1 Wuhan Sunrise Technology Development Company Information

13.28.2 Wuhan Sunrise Technology Development Alirocumab Product Offered

13.28.3 Wuhan Sunrise Technology Development Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Wuhan Sunrise Technology Development Main Business Overview

13.28.5 Wuhan Sunrise Technology Development Latest Developments

13.29 Wuhan Weisman Bioengineering

13.29.1 Wuhan Weisman Bioengineering Company Information

13.29.2 Wuhan Weisman Bioengineering Alirocumab Product Offered

13.29.3 Wuhan Weisman Bioengineering Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 Wuhan Weisman Bioengineering Main Business Overview

13.29.5 Wuhan Weisman Bioengineering Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Alirocumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Alirocumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Patent

Table 4. Major Players of Generic

Table 5. Global Alirocumab Sales by Type (2017-2022) & (Kg)

Table 6. Global Alirocumab Sales Market Share by Type (2017-2022)

Table 7. Global Alirocumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Alirocumab Revenue Market Share by Type (2017-2022)

Table 9. Global Alirocumab Sale Price by Type (2017-2022) & (US$/Kg)

Table 10. Global Alirocumab Sales by Application (2017-2022) & (Kg)

Table 11. Global Alirocumab Sales Market Share by Application (2017-2022)

Table 12. Global Alirocumab Revenue by Application (2017-2022)

Table 13. Global Alirocumab Revenue Market Share by Application (2017-2022)

Table 14. Global Alirocumab Sale Price by Application (2017-2022) & (US$/Kg)

Table 15. Global Alirocumab Sales by Company (2020-2022) & (Kg)

Table 16. Global Alirocumab Sales Market Share by Company (2020-2022)

Table 17. Global Alirocumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Alirocumab Revenue Market Share by Company (2020-2022)

Table 19. Global Alirocumab Sale Price by Company (2020-2022) & (US$/Kg)

Table 20. Key Manufacturers Alirocumab Producing Area Distribution and Sales Area

Table 21. Players Alirocumab Products Offered

Table 22. Alirocumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Alirocumab Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Alirocumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Alirocumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Alirocumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Alirocumab Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Alirocumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Alirocumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Alirocumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Alirocumab Sales by Country (2017-2022) & (Kg)

Table 34. Americas Alirocumab Sales Market Share by Country (2017-2022)

Table 35. Americas Alirocumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Alirocumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Alirocumab Sales by Type (2017-2022) & (Kg)

Table 38. Americas Alirocumab Sales Market Share by Type (2017-2022)

Table 39. Americas Alirocumab Sales by Application (2017-2022) & (Kg)

Table 40. Americas Alirocumab Sales Market Share by Application (2017-2022)

Table 41. APAC Alirocumab Sales by Region (2017-2022) & (Kg)

Table 42. APAC Alirocumab Sales Market Share by Region (2017-2022)

Table 43. APAC Alirocumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Alirocumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Alirocumab Sales by Type (2017-2022) & (Kg)

Table 46. APAC Alirocumab Sales Market Share by Type (2017-2022)

Table 47. APAC Alirocumab Sales by Application (2017-2022) & (Kg)

Table 48. APAC Alirocumab Sales Market Share by Application (2017-2022)

Table 49. Europe Alirocumab Sales by Country (2017-2022) & (Kg)

Table 50. Europe Alirocumab Sales Market Share by Country (2017-2022)

Table 51. Europe Alirocumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Alirocumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Alirocumab Sales by Type (2017-2022) & (Kg)

Table 54. Europe Alirocumab Sales Market Share by Type (2017-2022)

Table 55. Europe Alirocumab Sales by Application (2017-2022) & (Kg)

Table 56. Europe Alirocumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Alirocumab Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Alirocumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Alirocumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Alirocumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Alirocumab Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Alirocumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Alirocumab Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Alirocumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Alirocumab

Table 66. Key Market Challenges & Risks of Alirocumab

Table 67. Key Industry Trends of Alirocumab

Table 68. Alirocumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Alirocumab Distributors List

Table 71. Alirocumab Customer List

Table 72. Global Alirocumab Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Alirocumab Sales Market Forecast by Region

Table 74. Global Alirocumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Alirocumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Alirocumab Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Alirocumab Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Alirocumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Alirocumab Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Alirocumab Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Alirocumab Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Alirocumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Alirocumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Alirocumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Alirocumab Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Alirocumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Alirocumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Alirocumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. AK Scientific Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 93. AK Scientific Alirocumab Product Offered

Table 94. AK Scientific Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 95. AK Scientific Main Business

Table 96. AK Scientific Latest Developments

Table 97. Carbosynth Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Carbosynth Alirocumab Product Offered

Table 99. Carbosynth Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 100. Carbosynth Main Business

Table 101. Carbosynth Latest Developments

Table 102. TargetMol Chemicals Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 103. TargetMol Chemicals Alirocumab Product Offered

Table 104. TargetMol Chemicals Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 105. TargetMol Chemicals Main Business

Table 106. TargetMol Chemicals Latest Developments

Table 107. Beijing Aomi Jiade Pharmaceutical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 108. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offered

Table 109. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 110. Beijing Aomi Jiade Pharmaceutical Technology Main Business

Table 111. Beijing Aomi Jiade Pharmaceutical Technology Latest Developments

Table 112. Hefei Hirisun Pharmatech Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 113. Hefei Hirisun Pharmatech Alirocumab Product Offered

Table 114. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 115. Hefei Hirisun Pharmatech Main Business

Table 116. Hefei Hirisun Pharmatech Latest Developments

Table 117. Hubei Widely Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Hubei Widely Chemical Technology Alirocumab Product Offered

Table 119. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 120. Hubei Widely Chemical Technology Main Business

Table 121. Hubei Widely Chemical Technology Latest Developments

Table 122. Hubei Xingcheng Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 123. Hubei Xingcheng Biotechnology Alirocumab Product Offered

Table 124. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 125. Hubei Xingcheng Biotechnology Main Business

Table 126. Hubei Xingcheng Biotechnology Latest Developments

Table 127. Hubei Zhongshan Medical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 128. Hubei Zhongshan Medical Technology Alirocumab Product Offered

Table 129. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 130. Hubei Zhongshan Medical Technology Main Business

Table 131. Hubei Zhongshan Medical Technology Latest Developments

Table 132. Jiangxi Ruiweier Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 133. Jiangxi Ruiweier Biotechnology Alirocumab Product Offered

Table 134. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 135. Jiangxi Ruiweier Biotechnology Main Business

Table 136. Jiangxi Ruiweier Biotechnology Latest Developments

Table 137. Kailide Biomedical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 138. Kailide Biomedical Technology Alirocumab Product Offered

Table 139. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 140. Kailide Biomedical Technology Main Business

Table 141. Kailide Biomedical Technology Latest Developments

Table 142. Nantong Feiyu Biological Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 143. Nantong Feiyu Biological Technology Alirocumab Product Offered

Table 144. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 145. Nantong Feiyu Biological Technology Main Business

Table 146. Nantong Feiyu Biological Technology Latest Developments

Table 147. Nantong Hi-Future Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 148. Nantong Hi-Future Biotechnology Alirocumab Product Offered

Table 149. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 150. Nantong Hi-Future Biotechnology Main Business

Table 151. Nantong Hi-Future Biotechnology Latest Developments

Table 152. Shanghai Baishikai Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 153. Shanghai Baishikai Chemical Technology Alirocumab Product Offered

Table 154. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 155. Shanghai Baishikai Chemical Technology Main Business

Table 156. Shanghai Baishikai Chemical Technology Latest Developments

Table 157. Shanghai Biochempartner Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 158. Shanghai Biochempartner Alirocumab Product Offered

Table 159. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 160. Shanghai Biochempartner Main Business

Table 161. Shanghai Biochempartner Latest Developments

Table 162. Shanghai Loulan Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 163. Shanghai Loulan Biotechnology Alirocumab Product Offered

Table 164. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 165. Shanghai Loulan Biotechnology Main Business

Table 166. Shanghai Loulan Biotechnology Latest Developments

Table 167. Shanghai Macklin Biochemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 168. Shanghai Macklin Biochemical Alirocumab Product Offered

Table 169. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 170. Shanghai Macklin Biochemical Main Business

Table 171. Shanghai Macklin Biochemical Latest Developments

Table 172. Shanghai Minkai Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 173. Shanghai Minkai Biotechnology Alirocumab Product Offered

Table 174. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 175. Shanghai Minkai Biotechnology Main Business

Table 176. Shanghai Minkai Biotechnology Latest Developments

Table 177. Shanghai Ruihui Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 178. Shanghai Ruihui Chemical Technology Alirocumab Product Offered

Table 179. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 180. Shanghai Ruihui Chemical Technology Main Business

Table 181. Shanghai Ruihui Chemical Technology Latest Developments

Table 182. Shanghai Saimai Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 183. Shanghai Saimai Biotechnology Alirocumab Product Offered

Table 184. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 185. Shanghai Saimai Biotechnology Main Business

Table 186. Shanghai Saimai Biotechnology Latest Developments

Table 187. Shanghai Yifei Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 188. Shanghai Yifei Biotechnology Alirocumab Product Offered

Table 189. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 190. Shanghai Yifei Biotechnology Main Business

Table 191. Shanghai Yifei Biotechnology Latest Developments

Table 192. Sichuan Weiqi Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 193. Sichuan Weiqi Biotechnology Alirocumab Product Offered

Table 194. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 195. Sichuan Weiqi Biotechnology Main Business

Table 196. Sichuan Weiqi Biotechnology Latest Developments

Table 197. Taizhou KEDE Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 198. Taizhou KEDE Chemical Alirocumab Product Offered

Table 199. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 200. Taizhou KEDE Chemical Main Business

Table 201. Taizhou KEDE Chemical Latest Developments

Table 202. Taizhou Kerui Bio-Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 203. Taizhou Kerui Bio-Technology Alirocumab Product Offered

Table 204. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 205. Taizhou Kerui Bio-Technology Main Business

Table 206. Taizhou Kerui Bio-Technology Latest Developments

Table 207. Tianmen Hengchang Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 208. Tianmen Hengchang Chemical Alirocumab Product Offered

Table 209. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 210. Tianmen Hengchang Chemical Main Business

Table 211. Tianmen Hengchang Chemical Latest Developments

Table 212. WeiShi Reagent Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 213. WeiShi Reagent Alirocumab Product Offered

Table 214. WeiShi Reagent Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 215. WeiShi Reagent Main Business

Table 216. WeiShi Reagent Latest Developments

Table 217. Wuhan Dingxintong Pharmaceutical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 218. Wuhan Dingxintong Pharmaceutical Alirocumab Product Offered

Table 219. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 220. Wuhan Dingxintong Pharmaceutical Main Business

Table 221. Wuhan Dingxintong Pharmaceutical Latest Developments

Table 222. Wuhan Fortuna Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 223. Wuhan Fortuna Chemical Alirocumab Product Offered

Table 224. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 225. Wuhan Fortuna Chemical Main Business

Table 226. Wuhan Fortuna Chemical Latest Developments

Table 227. Wuhan Sunrise Technology Development Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 228. Wuhan Sunrise Technology Development Alirocumab Product Offered

Table 229. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 230. Wuhan Sunrise Technology Development Main Business

Table 231. Wuhan Sunrise Technology Development Latest Developments

Table 232. Wuhan Weisman Bioengineering Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors

Table 233. Wuhan Weisman Bioengineering Alirocumab Product Offered

Table 234. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 235. Wuhan Weisman Bioengineering Main Business

Table 236. Wuhan Weisman Bioengineering Latest Developments

List of Figures

Figure 1. Picture of Alirocumab

Figure 2. Alirocumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Alirocumab Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Alirocumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Alirocumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Patent

Figure 10. Product Picture of Generic

Figure 11. Global Alirocumab Sales Market Share by Type in 2021

Figure 12. Global Alirocumab Revenue Market Share by Type (2017-2022)

Figure 13. Alirocumab Consumed in Biochemical Reagents

Figure 14. Global Alirocumab Market: Biochemical Reagents (2017-2022) & (Kg)

Figure 15. Alirocumab Consumed in Pharmaceutical Intermediates

Figure 16. Global Alirocumab Market: Pharmaceutical Intermediates (2017-2022) & (Kg)

Figure 17. Global Alirocumab Sales Market Share by Application (2017-2022)

Figure 18. Global Alirocumab Revenue Market Share by Application in 2021

Figure 19. Alirocumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Alirocumab Revenue Market Share by Company in 2021

Figure 21. Global Alirocumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Alirocumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Alirocumab Sales Market Share by Region (2017-2022)

Figure 24. Global Alirocumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Alirocumab Sales 2017-2022 (Kg)

Figure 26. Americas Alirocumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Alirocumab Sales 2017-2022 (Kg)

Figure 28. APAC Alirocumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Alirocumab Sales 2017-2022 (Kg)

Figure 30. Europe Alirocumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Alirocumab Sales 2017-2022 (Kg)

Figure 32. Middle East & Africa Alirocumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Alirocumab Sales Market Share by Country in 2021

Figure 34. Americas Alirocumab Revenue Market Share by Country in 2021

Figure 35. United States Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Alirocumab Sales Market Share by Region in 2021

Figure 40. APAC Alirocumab Revenue Market Share by Regions in 2021

Figure 41. China Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Alirocumab Sales Market Share by Country in 2021

Figure 48. Europe Alirocumab Revenue Market Share by Country in 2021

Figure 49. Germany Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Alirocumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Alirocumab Revenue Market Share by Country in 2021

Figure 56. Egypt Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Alirocumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Alirocumab in 2021

Figure 62. Manufacturing Process Analysis of Alirocumab

Figure 63. Industry Chain Structure of Alirocumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370